Investment Summary |
|
|---|---|
| Date | 2009-07-01 |
| Target | PeriGen |
| Sector | Software |
| Investor(s) |
Trident Capital
Galen Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1993 |
| PE ASSETS | 1.9B USD |
| Size | Large |
| Type | Sector Focused |
Trident Capital was a venture capital firm focused on investments at all company stages, from early and expansion stage investments to buyouts and recapitalizations. Trident focused on investments in tech-enabled sectors, including enterprise software/services, outsourcing and payments, healthcare software/services, internet/consumer, and energy/clean tech. In 2015, Trident ceased investing and the Firm's employees split to form Sunstone Partners, a growth equity firm, and Trident Capital Cybersecurity, a venture firm focused on the cyber security sector.
| DEAL STATS | # |
|---|---|
| Overall | 66 of 86 |
| Sector: Software M&A | 14 of 18 |
| Type: Venture M&A Deals | 50 of 62 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 59 of 78 |
| Year: 2009 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-04-07 |
Aran Technologies
Co. Dublin, Ireland Arantech is the world leader in end-to-end customer experience management (CEM) software for wireless operators that is enabling a revolution in revenue generation possibilities in real time, for individual and corporate customers, for any service, in any location from any network, protocol or device. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-11-09 |
Datatel
Fairfax, Virginia, United States Datatel has focused exclusively on helping colleges and universities manage their business processes. Datatel today provides fully integrated enterprise information management software solutions to more than 600 colleges, universities and other higher education institutions serving almost 4 million students |
Sell | $570M |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1990 |
| PE ASSETS | 1.0B USD |
| Size | Large |
| Type | Sector Focused |
Galen Partners is a private equity firm that targets investments in the healthcare industry. Areas within healthcare that Galen will consider include medical devices & technology, specialty pharmaceuticals, and information technology/services. Galen typically invests between $10 and $30 million per transaction in companies with a proprietary product or service that have attained revenues above $10 million. Prospective transactions include growth equity investments, complete buyouts, family business or other recapitalizations, going-private transactions, roll-overs of a portion of existing equity, and management buyouts. Galen Partners was formed in 1990 and is based in Stamford, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 15 of 29 |
| Sector: Software M&A | 1 of 1 |
| Type: Venture M&A Deals | 8 of 13 |
| State: New Jersey M&A | 2 of 3 |
| Country: United States M&A | 15 of 28 |
| Year: 2009 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-10 |
Dow Pharmaceutical Sciences
Petaluma, California, United States Developer, manufacturer and marketer as well as formulator of topical therapies focused on the dermatology market. |
Sell | $285M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-11-01 |
Nautilus Neurosciences
Bedminster, New Jersey, United States Nautilus Neurosciences, Inc. is a neurology-focused specialty pharmaceutical company that identifies and develops drugs that could benefit those affected by neurological disorders. |
Buy | - |
